WASHINGTON, Sept. 11, 2017 /PRNewswire/ -- Vanda
Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA) today announced that it
will participate at the following upcoming investor conferences in
September 2017.
The Rodman and Renshaw
19th Annual Global Investment Conference in New York City on Tuesday, September 12, 2017. A corporate
presentation is scheduled for 2:35 p.m.
Eastern Time.
The Morgan Stanley 15th Annual Global Healthcare
Conference in New York City on
Wednesday, September 13, 2017. A
corporate presentation is scheduled for 2:10
p.m. Eastern Time.
The corporate presentation given at each conference will be
available live on Vanda's corporate website, where they also will
be archived for 30 days. To access the presentation, go to Vanda's
website at www.vandapharma.com and click on the Presentations tab
on the Investor Relations page. Please connect to the website
several minutes prior to the start of the live presentation.
About Vanda Pharmaceuticals Inc.
Vanda is a global biopharmaceutical company focused on the
development and commercialization of innovative therapies to
address high unmet medical needs and improve the lives of patients.
For more on Vanda, please visit www.vandapharma.com.
Company Contact:
Jim Kelly
Executive Vice President and Chief Financial Officer
Vanda Pharmaceuticals Inc.
(202) 734-3428
jim.kelly@vandapharma.com
View original
content:http://www.prnewswire.com/news-releases/vanda-pharmaceuticals-announces-participation-at-september-2017-investor-conferences-300517308.html
SOURCE Vanda Pharmaceuticals Inc.